Some governments have suggested that the detection of antibodies to SARS-CoV-2, the virus that causes COVID-19, could serve as the basis for an “immunity passport” or “risk-free certificate”, there is currently no evidence that people who have recovered from COVID-19 and have antibodies are protected from a second infection.
Lee más: Situation Report - 96 - Organización Mundial de la Salud - 25/04/2020
New online course released on the management of COVID-19 in aviation A new, interactive e-learning course titled “Operational considerations for managing COVID-19 cases/outbreak in aviation” has been developed based on the guidance document of the same name. It can be downloaded on personal computers and mobile phones and complements the COVID-19 at Points of Entry course "Management of ill travelers at points of entry in the context of the COVID-19 outbreak".
Lee más: Situation Report - 95 - Organización Mundial de la Salud - 24/04/2020
The Global Outbreak Alert and Response Network (GOARN) has launched a GOARN COVID-19 Knowledge hub. The hub is designed as a central repository of quality public health information, guidance, tools and webinars which can be accessed freely at any point. WHO Director-General Dr. Tedros, in his regular media briefing yesterday, cautioned that “we have a long way to go. This virus will be with us for a long time”. He added that “the world cannot go back to the way things were. There must be a “new normal” – a world that is healthier, safer and better prepared”.
Lee más: Situation Report - 94 - Organización Mundial de la Salud - 23/04/2020
WHO is deeply saddened at the death of a member of personnel during a security incident in Rakhine district of Myanmar, who was transporting COVID19 surveillance samples in support of the Ministry of Health and Sports. WHO condemns targeting of health workers involved in the COVID-19 response.
Lee más: Situation Report - 93 - Organización Mundial de la Salud - 22/04/2020
As of 21 April, over 100 countries have joined the Solidarity Trial to evaluate therapeutics for COVID-19. The trial will compare four treatment options against local standard of care, to assess their relative effectiveness against COVID-19.
Lee más: Situation Report - 92 - Organización Mundial de la Salud - 21/04/2020